Lakefront Biotherapeutics NV (WBO:LKFT) FCF Yield %: -18.57 (As of Jun. 25, 2026)


WBO:LKFT Lakefront Biotherapeutics NV WBO:LKFT
60 GF Score
Price €25.50
GF Value €104.25
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Lakefront Biotherapeutics NV FCF Yield %?

Lakefront Biotherapeutics NV WBO:LKFT +0.79% 60 FCF Yield % is -18.57 as of Jun. 25, 2026. GuruFocus rates WBO:LKFT with a GF Score™ of 60/100 and a GF Value™ of €104.25 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,417 Biotechnology companies, Lakefront Biotherapeutics NV ranks worse than 65.21% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Lakefront Biotherapeutics NV's Trailing 12-Month Free Cash Flow is €-310 Mil, and Market Cap is €1,671 Mil. Therefore, Lakefront Biotherapeutics NV's FCF Yield % for today is -18.57%.

The historical rank and industry rank for Lakefront Biotherapeutics NV's FCF Yield % or its related term are showing as below:

WBO:LKFT' s FCF Yield % Range Over the Past 10 Years
Min: -31.44   Med: -13.29   Max: 46.23
Current: -18.57


During the past 13 years, the highest FCF Yield % of Lakefront Biotherapeutics NV was 46.23%. The lowest was -31.44%. And the median was -13.29%.

WBO:LKFT's FCF Yield % is ranked worse than
65.21% of 1417 companies
in the Biotechnology industry
Industry Median: -9.7 vs WBO:LKFT: -18.57

Lakefront Biotherapeutics NV's FCF Margin % for the quarter that ended in Mar. 2026 was -1,278.71%.


Lakefront Biotherapeutics NV FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Lakefront Biotherapeutics NV FCF Yield % Related Terms


Lakefront Biotherapeutics NV FCF Yield % Historical Data

* Premium members only.

The historical data trend for Lakefront Biotherapeutics NV's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lakefront Biotherapeutics NV FCF Yield % Chart

Lakefront Biotherapeutics NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.74 -19.65 -17.41 -23.22 -14.73

Lakefront Biotherapeutics NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.57 -28.78 -13.58 -10.65 -19.87

WBO:LKFT vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Lakefront Biotherapeutics NV's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lakefront Biotherapeutics NV FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lakefront Biotherapeutics NV's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Lakefront Biotherapeutics NV's FCF Yield % falls into.


WBO:LKFT
60GF Score
Lakefront Biotherapeutics NV WBO:LKFT
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lakefront Biotherapeutics NV FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Lakefront Biotherapeutics NV's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-271.315 / 1842.48012
=-14.73%

Lakefront Biotherapeutics NV's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-82.873 * 4 / 1668.51204
=-19.87%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -18.57 mean?
Lakefront Biotherapeutics NV (WBO:LKFT) has a FCF Yield % of -18.57 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Lakefront Biotherapeutics NV and its competitors. According to the industry distribution chart, Lakefront Biotherapeutics NV ranks #924 out of 1417 companies in the Biotechnology industry, placing it in the top 65.2%.
Is Lakefront Biotherapeutics NV's FCF Yield % too high?
Lakefront Biotherapeutics NV's current FCF Yield % is -18.57. Based on the distribution chart, Lakefront Biotherapeutics NV ranks #924 out of 1417 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Lakefront Biotherapeutics NV has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lakefront Biotherapeutics NV's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Lakefront Biotherapeutics NV ranks #924 out of 1417 companies for FCF Yield %. This places Lakefront Biotherapeutics NV in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Lakefront Biotherapeutics NV and its competitors. Lakefront Biotherapeutics NV's current FCF Yield % is -18.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lakefront Biotherapeutics NV stock overvalued right now?
Based on GuruFocus' analysis, Lakefront Biotherapeutics NV (WBO:LKFT) is currently considered Possible Value Trap. The stock's GF Value™ is €104.25, compared to a current price of €25.50 — trading 75.5% below its estimated fair value. The current FCF Yield % is -18.57. Lakefront Biotherapeutics NV's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Lakefront Biotherapeutics NV (WBO:LKFT), the current FCF Yield % is -18.57 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lakefront Biotherapeutics NV (WBO:LKFT) Overvalued in 2026?

Based on GuruFocus' analysis, Lakefront Biotherapeutics NV stock appears to be undervalued. The current stock price of €25.50 is trading 75.5% below its estimated GF Value™ of €104.25. GuruFocus considers Lakefront Biotherapeutics NV to be Possible Value Trap.

Key valuation signals for WBO:LKFT:

  • FCF Yield %: -18.57
  • GF Value™: €104.25 vs. price of €25.50 (75.5% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the WBO:LKFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lakefront Biotherapeutics NV Business Description

Address Schalienhoevedreef 20 T, Mechelen, BEL, 2800
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
60GF Score

Get the complete analysis for WBO:LKFT

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€25.50
Price
€104.25
GF Value